Finding the best prices at pharmacies near you...

Prescription & Medication Blog

At RxSpark we believe prescription drugs and medication should be accessible and affordable for all Americans. In addition to the savings, discounts, and convenience that RxSpark provides, the RxSpark Blog is here to bring you information, news, current events, and important upates on topics that affect healthcare and prescription drugs. Be sure to check back frequently for updates, and if you find any information that is particularly helpful please don't hesitate to share!



Fiasp: New Rapid-Acting Mealtime Insulin Approved by FDA

Adults with type 1 or type 2 diabetes have a new treatment option available to them following the US Food and Drug Administration’s (FDA) decision to approve Novo Nordisk's rapid-acting mealtime insulin Fiasp (insulin aspart).  The drug is indicated to improve glycemic control in adults...

Read More

Juluca: New two drug HIV treatment approved by FDA

The US Food and Drug Administration (FDA) has approved the first once-daily, two-drug single pill treatment for certain patients with human immunodeficiency virus type 1 (HIV-1). Approval for Juluca (dolutegravir and rilpivirine) was granted to ViiV Healthcare, a global specialist in HIV owned by...

Read More

Tobacco products ‘still used by 20% of American adults’

Around 49 million American adults were still using tobacco products in 2015, according to new data published by the Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration’s (FDA) Center for Tobacco Products.  The Morbidity and Mortality Weekly Report...

Read More

Trelegy Ellipta: Triple therapy inhaler for COPD approved by FDA

The US Food and Drug Administration (FDA) has approved a new once-daily single inhaler triple therapy for treatment of certain adults with chronic obstructive pulmonary disease (COPD).  Trelegy Ellipta (furoate, umeclidinium, vilanterol) is indicated for patients on a fixed-dose combination...

Read More

First ever Erdheim-Chester Disease treatment approved by FDA

Zelboraf (vemurafenib) has been approved for treatment of adult patients with a rare cancer of the blood. It is the first medication approved by the US Food and Drug Administration (FDA) for treatment of Erdheim-Chester Disease (ECD).  ECD is a rare blood cancer originating in the bone...

Read More

CDC: Obesity ‘increases risk of 13 types of cancer’

Overweight or obese Americans are at a higher risk of developing cancer, according to the latest Vital Signs report from the Centers for Disease Control and Prevention (CDC). At least 13 different types of cancer are associated with obesity, yet figures suggest more than half of Americans are...

Read More

How to Minimize the Risk of Drug Side Effects

The majority of medication available over-the-counter or with a prescription comes with a risk of side effects, whether minor irritations or more serious health concerns. Each year, emergency rooms across the United States deal with more than 700,000 visits as a result of adverse drug events,...

Read More

FDA Commissioner outlines plans to tackle US opioid epidemic

Scott Gottlieb, MD, US Food and Drug Administration (FDA) Commissioner, has outlined the FDA's plans to tackle the nation's opioid abuse epidemic. Speaking to the House Committee on Energy and Commerce Hearing, he described opioid addiction as the "biggest crisis facing public health...

Read More

5 Tips to Help you Avoid Cold and Flu this Winter

It's that time of the year when the temperature starts to drop, winter weather is setting in, and more and more people are coming down with a cold or flu. It is important to stay healthy during the colder months of the year, but this is not always easy, particularly as you are increasingly exposed...

Read More

Depression 'higher among patients with atopic dermatitis'

Depression and anxiety is more commonly diagnosed in patients suffering atopic dermatitis than among the rest of the US population, a recent survey by the National Eczema Association (NEA) suggests. October is Eczema Awareness Month, during which the NEA is highlighting the impact of eczema on...

Read More

Psoriasis drug Stelara now indicated for adolescent patients

The US Food and Drug Administration (FDA) has approved the indication of Stelara (ustekinumab) for adolescent patients with moderate to severe plaque psoriasis. Janssen Biotech, the manufacturer of the drug, described the approval as a "significant milestone" in the treatment of young people with...

Read More